Pharma Co. Chiasma Can't Escape Investor Suit, Judge Rules
A Massachusetts federal judge on Thursday ruled that biopharmaceutical company Chiasma Inc. must face a proposed class action alleging investors in its 2015 initial public offering were misled about the prospects...To view the full article, register now.
Already a subscriber? Click here to view full article